Skip to main content
. 2019 Aug;31(4):557–577. doi: 10.21147/j.issn.1000-9604.2019.04.01

A15.

Prognosis of DLBCL patients accoding to IPI score

Risk group Number of risks 5-year DFS (%) 5-year OS (%)
DLBCL, diffuse large B cell lymphoma; IPI, international prognostic index; DFS, disease-free survival; OS, overall survival.
Low risk 0 or 1 70 73
Low-medium risk 2 50 51
High-medium risk 3 49 43
High risk 4 or 5 40 26